Sumant Kulkarni
Stock Analyst at Canaccord Genuity
Total Price Targets
6
Stocks Covered
4
Sectors
Healthcare
Most Recent
Apr 16, 2026
Notable Calls (Last 12 Months)
Stocks Covered by Sumant Kulkarni
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | $38.00 | $21.83 | +74.1% | 1 | Apr 16, 2026 |
| BIIB | Biogen Inc. | $265.00 | $186.69 | +41.9% | 2 | Feb 13, 2025 |
| ZVRA | Zevra Therapeutics, Inc. | $22.00 | $10.07 | +118.5% | 1 | Sep 18, 2024 |
| NBIX | Neurocrine Biosciences, Inc. | $164.00 | $131.64 | +24.6% | 2 | May 2, 2024 |
Recent Activity
- Apr 16, 2026— Set$38.00price target onDFTX(Definium Therapeutics, Inc.)
- Feb 13, 2025— Set$265.00price target onBIIB(Biogen Inc.)
- Sep 18, 2024— Set$22.00price target onZVRA(Zevra Therapeutics, Inc.)
- May 2, 2024— Set$164.00price target onNBIX(Neurocrine Biosciences, Inc.)
- Feb 28, 2022— Set$285.00price target onBIIB(Biogen Inc.)
- Aug 6, 2021— Set$108.00price target onNBIX(Neurocrine Biosciences, Inc.)
Frequently Asked Questions
Who is Sumant Kulkarni?
Sumant Kulkarni is a stock analyst at Canaccord Genuity covering 4 stocks primarily in Healthcare. They have issued 6 price targets since Aug 6, 2021.
What stocks does Sumant Kulkarni cover?
Sumant Kulkarni currently covers 4 stocks, including BIIB, NBIX, DFTX, ZVRA.
What is Sumant Kulkarni's latest price target?
Sumant Kulkarni's most recent price target was $38.00 on DFTX (Definium Therapeutics, Inc.), set on Apr 16, 2026.
What is Sumant Kulkarni's highest price target?
Sumant Kulkarni's highest issued price target is $285.00 on BIIB, set on Feb 28, 2022.
More Analysts at Canaccord Genuity
Coverage based on publicly published price targets. Not investment advice.